News for LFMD Stock

LifeMD to Participate in Two Investor Conferences During June LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy® LifeMD to Participate in Three Investor Conferences During May LifeMD Reports First Quarter 2025 Results and Raises Full-Year 2025 Guidance LifeMD Announces Plans to Expand Affordable Access to Wegovy® for Cash-Pay Patients Medifast Announces First Quarter 2025 Financial Results LifeMD to Report First Quarter 2025 Financial Results on May 6 LifeMD Acquires Women’s Health Provider Optimal Human Health MD to Accelerate Entry into the Women’s Health Market LifeMD Expands Insurance Acceptance to Medicare Beneficiaries for Qualifying Virtual Primary Care, Including in its Weight Loss Programs Medifast to Announce Financial Results for the First Quarter Ended March 31, 2025 LifeMD to Participate in the 24th Annual Needham Virtual Healthcare Conference LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock LifeMD Reports Fourth Quarter 2024 Results LifeMD® Announces Integration with LillyDirect Pharmacy Provider to Offer Patients Streamlined Access to Branded Dual GLP-1/GIP Zepbound LifeMD to Participate in the KeyBanc Capital Markets Healthcare Forum LifeMD to Report Fourth Quarter 2024 Financial Results on March 10 LifeMD® Announces Entry Into the Behavioral Health Market Medifast Announces Fourth Quarter and Full Year 2024 Financial Results Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2024 LifeMD to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference Medifast Introduces New High-Protein Product Line OPTAVIA ASCEND™ For GLP-1 Users & Those Looking for Help to Keep Weight Off LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock Medifast Survey Finds Majority of U.S. Adults Trying to Lose Weight Agree Lifestyle Changes Are Essential – Even with Weight Loss Medications LifeMD to Participate in the Mizuho Health Care Conference: Medical Device, Services, Technology and Distribution LifeMD to Participate in Three Investor Conferences During November LifeMD Reports Third Quarter 2024 Results LifeMD® Launches Affiliated Pharmacy to Drive End-to-End Patient Care and Operational Efficiency Medifast Announces Third Quarter 2024 Financial Results LifeMD® to Report Third Quarter 2024 Financial Results on November 7 Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2024 LifeMD® Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock LifeMD Announces Major Enhancements to its Weight Management Program, Expanding Patient Access to Branded GLP-1 Therapies and Introducing New Treatment Options LifeMD to Participate in Three Investor Conferences During September LifeMD Reports Second Quarter 2024 Results Medifast Announces Second Quarter 2024 Financial Results LifeMD to Report Second Quarter 2024 Financial Results on August 7 LifeMD to Participate in Two Investor Conferences During August Medifast to Announce Financial Results for the Second Quarter Ended June 30, 2024 LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock LifeMD Launches Commercial Health Insurance Acceptance for its Primary Care Services, Including Weight Management Medifast Named as One of The “Best Companies To Work For” by U.S. News & World Report LifeMD to Participate in the Truist Securities Healthcare Disruptors & Digital Health Summit LifeMD Set to Join the Russell 3000 Index Medifast Continues Business Transformation, Launching National Marketing Campaign Promoting its Holistic Offering for Customers Utilizing and Considering Weight Loss Medications LifeMD Reports First Quarter 2024 Results; Raises Full Year Revenue Guidance LifeMD Becomes the First Virtual Primary Care Provider to Elevate GLP-1 Patient Care with Real-time, At-Home Monitoring of Blood Pressure and Body Composition LifeMD Appoints Dr. Calum MacRae to its Board of Directors LifeMD to Report First Quarter 2024 Financial Results on May 8 LifeMD to Participate in Upcoming Investor and Industry Conferences During May LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock LifeMD to Participate in the 23rd Annual Needham Virtual Healthcare Conference LifeMD Reports Fourth Quarter 2023 Results LifeMD to Report Fourth Quarter 2023 Financial Results on March 11 LifeMD to Participate in Upcoming Investor Conferences and Webinar LifeMD to Participate in the 11th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference LifeMD to Participate in the Maxim Group 2024 Healthcare IT Virtual Conference LifeMD Provides 2024 Financial Guidance LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock Medifast Initiates Business Transformation by Entering the Medically Supported Weight Loss Market through Collaboration with LifeMD, a Virtual Primary Care Provider, and Adjusting its Capital Allocation Policy LifeMD and Medifast Partner to Offer Transformative Weight Management Solution LifeMD Executives to Participate in RWJBarnabas Health’s Telehealth Symposium LifeMD to Participate in Upcoming Investor Conferences and Panel Discussions LifeMD Reports Third Quarter 2023 Results; Record Revenue and Adjusted EBITDA LifeMD Ranked Number 166 Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500™ LifeMD to Report Third Quarter 2023 Financial Results on November 8 Particle Health and LifeMD Demonstrate the Potential of Using Comprehensive Electronic Health Record Data to Triage Patients for GLP-1 Weight Management Therapy LifeMD to Participate in Two Investor Conferences in October LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock LifeMD and ASCEND Therapeutics Launch Integrated Direct-to-Consumer Telehealth Model for Hormone Therapy LifeMD to Participate in Two Investor Conferences in September LifeMD Reports Second Quarter 2023 Results; Achieves Positive Free Cash Flow and Raises 2023 Revenue Guidance LifeMD to Present at Sidoti’s Micro-Cap Virtual Conference LifeMD to Report Second Quarter 2023 Financial Results on August 9 LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock LifeMD Elevates Successful GLP-1 Weight Management Program with Proprietary Platform Enhancements LifeMD Appoints William J. Febbo to its Board of Directors LifeMD, Inc. to Present at the June 1st Virtual Investor Summit LifeMD, Inc. Reports First Quarter 2023 Results; Record Revenues and Adjusted EBITDA LifeMD and HealthWarehouse.com Partner in Exclusive Telehealth Agreement LifeMD, Inc. to Announce First Quarter 2023 Financial Results on May 12, 2023 LifeMD Launches New Features and Membership Plans to Improve Patient Experience and Broaden Access to Healthcare LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock LifeMD, Inc. Reports Fourth Quarter/ Full Year 2022 Results; Achieves Consolidated Adjusted EBITDA Profitability LifeMD, Inc. Announces Closing of New $40 Million Credit Facility LifeMD, Inc. to Announce Fourth Quarter, Full Year 2022 Financial Results on March 22, 2023 LifeMD Appoints Dr. Joan LaRovere to its Board of Directors LifeMD Appoints Jessica Friedeman as Chief Marketing Officer to Support the Company’s Rapid Expansion into Virtual Primary Care LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock LifeMD, Inc. Ranked Number 140 Fastest Growing Company on Deloitte’s 2022 North America Technology Fast 500™ LifeMD, Inc. to Participate in Upcoming Investor Conferences LifeMD, Inc. Reports Third Quarter 2022 Results LifeMD, Inc. to Announce Third Quarter 2022 Financial Results and Host Conference Call on November 10, 2022 LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock LifeMD Appoints Bobby Jindal to the Board of Directors LifeMD Expands Primary Care Platform’s Diagnostic Capabilities with New At-Home Screening Kits For Early Warning Signs Of Cancer LifeMD and Cleared Offer New Hope to Allergy Patients Through Strategic Partnership With Allergenis LifeMD, Inc. Reports Second Quarter 2022 Results LifeMD, Inc. to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 11, 2022 LifeMD Announces Continued and Rapid Expansion of Virtual Primary Care To over 200 Conditions LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock LifeMD, Inc. Reports First Quarter 2022 Results LifeMD to Announce First Quarter Financial Results and Host Conference Call on Friday, May 13 LifeMD to Participate in the Upcoming May Conferences LifeMD to Participate in the 21st Annual Needham Virtual Healthcare Conference LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock LifeMD Launches Proprietary Over-the-Counter Skincare Line for Women, Expanding Teledermatology Offerings LifeMD to Participate in the KeyBanc Virtual Healthcare Conference LifeMD Reports Fourth Quarter and Full Year 2021 Results LifeMD, Inc. to Announce Year End 2021 Financial Results and Host Conference Call on Monday, March 7 In Transformational Step, LifeMD Launches Primary Care Platform Nationwide Following Beta Launch LifeMD to Host 2022 Virtual Analyst and Investor Day LifeMD to Participate in the Upcoming February Investor Conferences LifeMD Provides Initial FY2022 Guidance and Announces Preliminary FY2021 Revenues LifeMD to Participate in the Upcoming Virtual BTIG Conference LifeMD Expands Patient Offerings by Acquiring Leading Allergy Telehealth Platform LifeMD Announces Key Appointments to Drive Launch of Proprietary Virtual Care Platform LifeMD to Participate in Panel Presentation at LifeSci Partners Corporate Access Event 2022 LifeMD to Participate in Upcoming January Investor Conferences LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock LifeMD to Participate in the Stephens Annual Investment Conference LifeMD Reports Q3 2021 Revenue Up 127% to Record $24.9 Million and 24% Sequential Improvement in Adjusted EBITDA LifeMD Launches Virtual Care Platform, Bringing Accessible, Affordable Healthcare to Patients Nationwide LifeMD to Present at the Credit Suisse Virtual Annual Healthcare Conference LifeMD to Release Third Quarter 2021 Financial Results on Wednesday, November 10, 2021 LifeMD Announces Closing of Public Offering 1,400,000 Shares of 8.875% Series A Cumulative Perpetual Preferred Stock LifeMD Announces Closing of Public Offering of Common Stock and Exercise of the Underwriters’ Option LifeMD Announces Pricing of Public Offering 1,400,000 Shares of 8.875% Series A Cumulative Perpetual Preferred Stock LifeMD Announces Pricing of Public Offering of Common Stock LifeMD Announces Launch of Public Offering of Common Stock LifeMD Announces Launch of Public Offering of 1,400,000 Shares of Preferred Stock LifeMD to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference LifeMD Appoints Seasoned Investor Naveen Bhatia to Board of Directors LifeMD to Present at the H.C. Wainwright Annual Global Investment Conference LifeMD Partners With Prescryptive Health, Expanding Convenience and Affordability for Patients LifeMD Reports Q2 2021 Revenue Up 145% to Record $22.3 Million, Driven by Reduced Acquisition Costs and Strong Retention LifeMD, Inc. Partners With Particle Health to Provide Comprehensive Health Records Offering a More Personalized Approach to Medical Care LifeMD to Release Second Quarter 2021 Financial Results on Thursday, August 12, 2021 LifeMD Teams with a Leading Provider of Diagnostic Services and Axle Health to Deliver Telehealth Access to At-Home Diagnostics LifeMD Names Experienced Pharma Executive Alexander Mironov as President LifeMD™ Completes $15M Debt Financing LifeMD to Present at Upcoming June Investor Conferences Plaintiffs in Shareholder Suits Drop Claims Against LifeMD LifeMDᵀᴹ Appoints Prominent Dermatologist Dr. Matthew Zipoli as a Lead Medical Advisor for Tele-dermatology Brand Nava MDᵀᴹ  Star Actresses Kate del Castillo and Bellamy Young Partner With LifeMD as Brand Ambassadors For Shapiro MD LifeMD™ Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) LifeMD Reports Q1 2021 Revenue up 323% to Record $18.2M, Raises Full Year Revenue Guidance to $90-$100M LifeMD to Release First Quarter 2021 Financial Results on Thursday, May 13, 2021 LifeMD Announces Expected Record Revenue of $18.2M for Q1’21, Up 323% Vs. Q1’20, Due to Growth in Subscriptions and Patient Acquisition Short-Seller’s Note is Short on Credibility, LifeMD Says LifeMD Responds to Anonymous Short “Report” LifeMD Launches NavaMD™ Adding Direct-to-Patient Clinical Skincare Services to its Portfolio of Personalized Telehealth Brands LifeMD Reports Q4 2020 Revenue up 227% to Record $12.9 Million, Full Year up 199% to Record $37.3 Million LifeMD to Host Fourth Quarter and Full Year 2020 Conference Call on Monday, March 29, 2021 at 4:30 p.m. ET LifeMD Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) LifeMD to Participate at the 33rd Annual Virtual ROTH Conference on March 15-17, 2021 LifeMD Q1 2021 Revenues on Track to Exceed $17 Million, up 295%, with Subscriptions Representing More than 80% of Total Revenue Conversion Labs Begins Trading Under New Company Name, LifeMD, and Ticker Symbol, LFMD